Citation: Sc. Pefile et al., RELEASE OF ROOPEROL TETRAACETATE FROM TOPICAL BASES - IN-VITRO STUDIES USING SILICONE MEMBRANE, International journal of pharmaceutics, 161(2), 1998, pp. 237-243
Authors:
ALBRECHT CF
SIGLE JP
VONVELTHOVEN V
JACKISCH R
FEUERSTEIN TJ
Citation: Cf. Albrecht et al., MODULATION OF ACETYLCHOLINE (ACH) RELEASE IN HUMAN NEOCORTEX BY DELTA(1)-OPIOID RECEPTORS ON SOMATOSTATIN INTERNEURONS, Naunyn-Schmiedeberg's archives of pharmacology, 358(4), 1998, pp. 1-1
Citation: Sc. Pefile et al., THE VALIDATION OF A NEW STABILITY-INDICATING HPLC TECHNIQUE DEVELOPEDFOR THE QUANTITATIVE-ANALYSIS OF ROOPEROL TETRAACETATE, Journal of liquid chromatography & related technologies, 20(18), 1997, pp. 3061-3072
Authors:
DONALD PR
LAMPRECHT JH
FREESTONE M
ALBRECHT CF
BOUIC PJD
KOTZE D
VANJAARSVELD PP
Citation: Pr. Donald et al., A RANDOMIZED PLACEBO-CONTROLLED TRIAL OF THE EFFICACY OF BETA-SITOSTEROL AND ITS GLUCOSIDE AS ADJUVANTS IN THE TREATMENT OF PULMONARY TUBERCULOSIS, The international journal of tuberculosis and lung disease, 1(6), 1997, pp. 518-522
Authors:
BOUIC PJD
ETSEBETH S
LIEBENBERG RW
ALBRECHT CF
PEGEL K
VANJAARSVELD PP
Citation: Pjd. Bouic et al., BETA-SITOSTEROL AND BETA-SITOSTEROL GLUCOSIDE STIMULATE HUMAN PERIPHERAL-BLOOD LYMPHOCYTE-PROLIFERATION - IMPLICATIONS FOR THEIR USE AS AN IMMUNOMODULATORY VITAMIN COMBINATION, International journal of immunopharmacology, 18(12), 1996, pp. 693-700
Authors:
COETZEE JF
KRUGER PB
ALBRECHT CF
JAHED N
VANJAARSVELD PP
Citation: Jf. Coetzee et al., PHARMACOKINETIC BEHAVIOR AND CARDIOVASCULAR EFFECTS OF INTRAVENOUSLY ADMINISTERED HYPOXOSIDE AND ROOPEROL, Arzneimittel-Forschung, 46(10), 1996, pp. 997-1000
Citation: Cf. Albrecht et al., MORPHOLOGICAL CHARACTERIZATION OF THE CELL-GROWTH INHIBITORY ACTIVITYOF ROOPEROL AND PHARMACOKINETIC ASPECTS OF HYPOXOSIDE AS AN ORAL PRODRUG FOR CANCER-THERAPY, South African medical journal, 85(9), 1995, pp. 853-860
Authors:
ALBRECHT CF
KRUGER PB
SMIT BJ
FREESTONE M
GOUWS L
MILLER R
VANJAARSVELD PP
Citation: Cf. Albrecht et al., THE PHARMACOKINETIC BEHAVIOR OF HYPOXOSIDE TAKEN ORALLY BY PATIENTS WITH LUNG-CANCER IN A PHASE-I TRIAL, South African medical journal, 85(9), 1995, pp. 861-865
Authors:
SMIT BJ
ALBRECHT CF
LIEBENBERG RW
KRUGER PB
FREESTONE M
GOUWS L
THERON E
BOUIC PJD
ETSEBETH S
VANJAARSVELD PP
Citation: Bj. Smit et al., A PHASE-I TRIAL OF HYPOXOSIDE AS AN ORAL PRODRUG FOR CANCER-THERAPY -ABSENCE OF TOXICITY, South African medical journal, 85(9), 1995, pp. 865-870